Docetaxel in Combination with Dacarbazine in Patients with Advanced Melanoma

Publisher： Karger

E-ISSN： 1423-0232|63|4|333-337

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.4, 2002-11, pp. : 333-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dacarbazine, Nimustine Hydrochloride, Cisplatin and Tamoxifen Combination Chemotherapy for Advanced Malignant Melanoma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 26, Iss. 8, 1999-08 ,pp. : 489-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of tipifarnib in combination with docetaxel in patients with advanced solid malignancies

By Awada Ahmad   Zhang Steven   Gil Thierry   de Valeriola Dominique   Lalami Yassine   De Porre Peter   Piccart-Gebhart Martine J.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 991-1003

Informa Healthcare

Access to resources Recommend Favorite

Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298)

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 303-309

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of Docetaxel in Combination with Gefitinib in Gemcitabine-Pretreated Patients with Advanced/Metastatic Pancreatic Cancer

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Effective Combination Chemotherapy with Bimonthly Docetaxel and Cisplatin with or without Hematopoietic Growth Factor Support in Patients with Advanced Gastroesophageal Cancer

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 211-217

Karger

Access to resources Recommend Favorite